written on 27.05.2014

IFC loan launches Jubilant's plan to decouple pharma


Global development institution IFC's $147.5m financial package to Jubilant Pharma, a wholly owned Singapore-based arm of India's Jubilant Life Sciences, is expected to set in motion the group's plans to consolidate its pharmaceuticals business under its…

Latest Reports